5月23日,药明康德(603259/02359)发布公告,涉及5亿美元于2025年到期的零息有担保可转换债券的转让价调整。公告中提到,因2024年利润分配及2025年特别股息分派,债券的转让价将由每股H股80.02港元调整为每股H股78.28港元,自2025年5月24日起生效。假设所有债券按调整后的转让价转让,将导致已发行H股股本从约4852万股增至约4960万股,相当于公告日期公司已发行H股股本...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.